Log in
Enquire now

List of Rosalind Franklin University of Medicine and Science patents

List of Rosalind Franklin University of Medicine and Science patents
List of UtopiaCompression patents
List of MOBOTIX AG patents
List of Steinbichler Optotechnik GmbH patents
List of companies in Sinopharm Capital's investment portfolio
List of SaaS companies in Texas
Patents where
Current Assignee
Name
is
Rosalind Franklin University of Medicine and ScienceRosalind Franklin University of Medicine and Science
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11559231 System and method for determining a discrimination index for fear-potentiated startle

Patent 11559231 was granted and assigned to Rosalind Franklin University of Medicine and Science on January, 2023 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
11559231
January 24, 2023
‌
US Patent 7780949 Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases

Patent 7780949 was granted and assigned to Rosalind Franklin University of Medicine and Science on August, 2010 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
7780949
August 24, 2010
‌
US Patent 10351608 CCN3 and CCN3 peptides and analogs thereof for therapeutic use

Patent 10351608 was granted and assigned to Rosalind Franklin University of Medicine and Science on July, 2019 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
10351608
July 16, 2019
‌
US Patent 9114112 CCN3 and CCN3 peptides and analogs thereof for therapeutic uses

Patent 9114112 was granted and assigned to Rosalind Franklin University of Medicine and Science on August, 2015 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9114112
August 25, 2015
‌
US Patent 9840709 Antisense compounds targeting genes associated with cystic fibrosis

Patent 9840709 was granted and assigned to Rosalind Franklin University of Medicine and Science on December, 2017 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9840709
December 12, 2017
‌
US Patent 10525076 Antisense compounds targeting genes associated with cystic fibrosis

Patent 10525076 was granted and assigned to Rosalind Franklin University of Medicine and Science on January, 2020 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
10525076
January 7, 2020
‌
US Patent 11505582 CCN3 and CCN3 peptides and analogs thereof for therapeutic use

Patent 11505582 was granted and assigned to Rosalind Franklin University of Medicine and Science on November, 2022 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
11505582
November 22, 2022
‌
US Patent 10544417 Antisense compounds targeting genes associated with cystic fibrosis

Patent 10544417 was granted and assigned to Rosalind Franklin University of Medicine and Science on January, 2020 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
10544417
January 28, 2020
‌
US Patent 7261887 None

Patent 7261887 was granted and assigned to Rosalind Franklin University of Medicine and Science on August, 2007 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
7261887
August 28, 2007
‌
US Patent 7211257 Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody

Patent 7211257 was granted and assigned to Rosalind Franklin University of Medicine and Science on May, 2007 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
7211257
May 1, 2007
‌
US Patent 9725429 Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium release

Patent 9725429 was granted and assigned to Rosalind Franklin University of Medicine and Science on August, 2017 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9725429
August 8, 2017
‌
US Patent 10011578 Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release

Patent 10011578 was granted and assigned to Rosalind Franklin University of Medicine and Science on July, 2018 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
10011578
July 3, 2018
‌
US Patent 9327017 Leishmania-based carrier for vaccine delivery

Patent 9327017 was granted and assigned to Rosalind Franklin University of Medicine and Science on May, 2016 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9327017
May 3, 2016
‌
US Patent 9556434 Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome

Patent 9556434 was granted and assigned to Rosalind Franklin University of Medicine and Science on January, 2017 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9556434
January 31, 2017
‌
US Patent 9970056 Methods and kits for diagnosing, prognosing and monitoring parkinson's disease

Patent 9970056 was granted and assigned to Rosalind Franklin University of Medicine and Science on May, 2018 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9970056
May 15, 2018
‌
US Patent 9839389 Foot-strength test device and methods for use

Patent 9839389 was granted and assigned to Rosalind Franklin University of Medicine and Science on December, 2017 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9839389
December 12, 2017
‌
US Patent 8648053 Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for Usher syndrome

Patent 8648053 was granted and assigned to Rosalind Franklin University of Medicine and Science on February, 2014 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
8648053
February 11, 2014
‌
US Patent 9753042 Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures

Patent 9753042 was granted and assigned to Rosalind Franklin University of Medicine and Science on September, 2017 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9753042
September 5, 2017
‌
US Patent 9102645 Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release

Patent 9102645 was granted and assigned to Rosalind Franklin University of Medicine and Science on August, 2015 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9102645
August 11, 2015
‌
US Patent 7238347 Suicidal mutant

Patent 7238347 was granted and assigned to Rosalind Franklin University of Medicine and Science on July, 2007 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
7238347
July 3, 2007
‌
US Patent 10729370 Mobile sensor system and methods for use

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
10729370
August 4, 2020
‌
US Patent 11116785 Antisense compounds targeting genes associated with cystic fibrosis

Patent 11116785 was granted and assigned to Rosalind Franklin University of Medicine and Science on September, 2021 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
11116785
September 14, 2021
‌
US Patent 9532961 Method and kit for administering γ-glutamyl-D-cysteine for the prevention of reperfusion injury following ischemic stroke

Patent 9532961 was granted and assigned to Rosalind Franklin University of Medicine and Science on January, 2017 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
9532961
January 3, 2017
‌
US Patent 8772468 Splice variant specific messenger RNA transcripts as biomarkers of parkinson's disease

Patent 8772468 was granted and assigned to Rosalind Franklin University of Medicine and Science on July, 2014 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
8772468
July 8, 2014
‌
US Patent 7956037 Cytoprotective therapeutic agents for the prevention of reperfusion injury following ischemic stroke

Patent 7956037 was granted and assigned to Rosalind Franklin University of Medicine and Science on June, 2011 by the United States Patent and Trademark Office.

Rosalind Franklin University of Medicine and Science
Rosalind Franklin University of Medicine and Science
United States Patent and Trademark Office
United States Patent and Trademark Office
7956037
June 7, 2011
Results per page:
31 results
0 selected
31 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us